ABSTRACT: Several N-acyl ciprofloxacin quinone derivatives based on a trimethyl lock structure were synthesized, and their in vitro antibacterial activity against a panel of clinically relevant bacteria was evaluated. A few new analogues displayed enhanced activity against Gram-positive species compared to the parent drug. Additionally, studies of 8-Cip, which was the most potent compound tested, indicate that it may act through a dual-action mechanism.
S
ince their discovery in 1970s, fluoroquinolone antibiotics have played an important role in treatment of bacterial infections and have saved countless millions of lives. Targeting bacterial DNA gyrase and topoisomerase, fluoroquinolones exhibit their significant bactericidal activity by forming ternary complexes of enzyme−DNA−drug and consequently blocking bacterial replication. 1, 2 Their notable antimicrobial activity, excellent pharmacokinetic properties, and few side effects have led to the widespread use of fluoroquinolones and, unfortunately, thus also the development of bacterial resistance. 3 Therefore, although many advances in the search for new fluoroquinolones have been already made, there is a sense of urgency for new and more effective derivatives.
Recently, in our development of linkers to incorporate a drug release function in iron transport-mediated drug delivery, a series of carboxylic acids with a quinone "trimethyl lock" structure and their methyl esters were obtained as synthetic intermediates. 4, 5 The chemical nature of the trimethyl lock is an o-hydroxylcinnamic acid derivative. 6 Reduction of the quinone trimethyl lock system generalized by structure 1 would lead to the corresponding hydroquinones 2 in which severe steric repulsion between three methyl groups promotes rapid lactonization with concomitant release of an alcohol or amine (Scheme 1). 7, 8 Several quinone trimethyl lock compounds have been investigated for reductase-activated prodrugs such as those based on mustard 9 and oxindoles 10 for anticancer therapy. In ciprofloxacin, one of the best known fluoroquinolones, it has been demonstrated that chemical modification of the secondary amine in the piperazinyl ring by acylation does not always alter the effect of these molecules toward their bacterial target.
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With the aim of probing the effects of the quinone trimethyl lock on antibacterial activity of fluoroquinonlones, we herein describe the syntheses of several ciprofloxacin derivatives with quinone trimethyl lock precursors as N-acyl substituents and studies of their in vitro antibacterial activity.
The syntheses of trimethyl locks with different substituents on the quinone are shown in Scheme 2. Both forms 5H and 8H were derived from lactone 4 by oxidative ring opening of the 8 and N-bromosuccinimide, 12 respectively. The acids were conveniently converted to their methyl esters 5Me and 8Me via thionyl chloride-mediated or acid catalyzed esterification in methanol. Nucleophilic substitution of 5Me with NaN 3 in aqueous methanol provided azide 6 in excellent yield. A triphenylphosphine-mediated reduction of the azide afforded vinylogous amide 7Me in 66% yield, which was subsequently hydrolyzed to furnish acid 7H. Water-soluble carbodiimidemediated coupling of ciprofloxacin to quinone trimethyl locks 5H, 7H, and 8H provided N-acyl ciprofloxacin derivatives 5-Cip, 7-Cip, and 8-Cip with different substituents (Br-, NH 2 -, H-) on the quinone moieties in 44−71% yield (Scheme 3).
N-Acyl ciprofloxacin quinone derivatives 5-Cip, 7-Cip, and 8-Cip were initially screened for antibiotic activity against representative Gram-positive and Gram-negative bacteria as well as Mycobacterium vaccae using agar diffusion assays (Table 1 ). All three ciprofloxacin derivatives displayed strong antibacterial activities when tested at 0.1 mM, as indicated by the large zones of inhibition they induced. The trimethyl lock cores, as represented by methyl esters 5Me, 7Me, and 8Me, were generally inactive. Moreover, all three ciprofloxacin derivatives showed moderate to good activity against Mycobacterium vaccae, a nonpathogenic model organism for Mycobacterium tuberculosis that causes tuberculosis, suggesting their potential in antituberculosis agent development.
All ciprofloxacin derivatives were subjected to further assays to determine their minimum inhibitory concentrations (MIC) ( Table 2) . Two additional N-acyl derivatives 9 and 10 that have similar trimethyl substituted side chain structures but without the quinone fragment were also synthesized and included in the assay. In general, the trimethyl lock ciprofloxacin quinone derivatives possessed equal or enhanced in vitro activity against Gram-positive species compared to the parent drug. Among the three derivatives, compound 8-Cip was the most active with MIC values less than 0.05 and 0.2 μM against S. aureus and M. luteus, respectively, against which ciprofloxacin is less active (MIC in 0.47 and 8 μM, respectively). However, 9 and 10 were less active than the trimethyl lock ciprofloxacin derivatives, indicating that the quinone structure plays a key role for the activity enhancement observed. In fact, trimethyl lock compound 8Me has very weak antibacterial activity (MIC = 50−80 μM) against the Gram-positive species tested except S. aureus, suggesting that the trimethyl lock ciprofloxacin derivatives may be dual-action antibiotics.
The trimethyl lock ciprofloxacin derivatives displayed decreased activity (2−50-fold) against mycobacteria and Gramnegative bacteria compared to the parent drug, presumably because of the loss of zwitterionic structure of ciprofloxacin, 
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Letter which favors membrane penetration. 15 However, 9 and 10 were virtually inactive (MIC > 100 μM) against Gram-negative bacteria, suggesting that the quinone fragment partially compensates for the loss of activity caused by the nonzwitterionic structure.
Based on results from antibacterial assays and the chemical nature of the trimethyl lock system, we have proposed modes of action of the trimethyl lock ciprofloxacin derivatives. While all three derivatives could serve as prodrugs, which are activated by potential reductases as depicted in Scheme 1, compound 8-Cip may have an additional dual-action mechanism by serving as a prodrug and as a covalent enzyme inhibitor, which is consistent with its superior antibacterial activity. Conjugate addition of sulfur nucleophiles to quinones is well-known and has been exploited in design of certain enzyme inhibitors. 16 Similarly, the activation of compound 8-Cip could be initiated by the reductive alkylation with certain thiol-containing enzymes (Scheme 4). The resulting thiol-quinone adduct 11 would be expected to aromatize to the corresponding hydroquinone 12. The rapid lactonization of 12 induced by the trimethyl lock could release ciprofloxacin and meanwhile result in a covalent inactivated enzyme 13. In contrast, such a pathway with an aromatization step could not be established for compounds 5-Cip and 7-Cip.
To determine whether 8-Cip could be activated in the presence of thiol-containing enzymes as proposed, model reactions were examined for the reaction of thiols with N-acyl phenylpiperazine 8-PP, a more soluble alternative to 8-Cip, and the reaction was monitored by HPLC (Scheme 5). The thiol methyl mercaptoacetate was chosen for the model studies principally because its pK a (7.9) was similar to that of the thiol in cysteine (pK a = 8), which is ubiquitous in biological systems. We were pleased to find that in the presence of the thiol, 8-PP (retention time = 11.1 min) was largely converted to lactone 14 (retention time = 9.2 min) with concomitant release of the phenylpiperazine (retention time = 8.5 min) in buffered aqueous acetonitrile after 3 h. In sharp contrast, no reaction was observed for compound 7-PP, a representative system lacking the aromatization pathway, under the same conditions that led to rapid lactonization for 8-PP. These data provide evidence for 8-Cip being a dual-action prodrug that might utilize a unique thiol-activated pathway.
In summary, we have described the syntheses of a series of ciprofloxacin derivatives with a quinone trimethyl lock as the N-acyl substituent and their antibacterial activity. Among the derivatives, compound 8-Cip displayed enhanced activity against several Gram-positive species compared to the parent drug. The superior activity of 8-Cip suggests that it may act through a dual-action mechanism by serving as a prodrug and as a covalent thiol-containing enzyme inhibitor. This dualaction mechanism also has great potential for use in enzymeactivated prodrug strategies for site-selective drug delivery. Future work will focus on syntheses of other drug derivatives based on 8H and examine the release of drug in appropriate enzyme assays.
Experimental procedures, copies of spectral data, and characterization data. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/ acsmedchemlett.5b00146.
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